Bristol Laboratories recalls Phenoxymethylpenicillin due to labeling issues
Bristol Laboratories Limited is recalling batch 7124002 of Phenoxymethylpenicillin 250 mg/5 ml Oral Solution due to labeling issues.
Company
Bristol Laboratories Limited
Signal assessment
Signal strength
moderate
Confidence level
moderate
Why it matters
The recall of Phenoxymethylpenicillin due to labeling issues highlights potential vulnerabilities in the antibiotic supply chain. This situation may create opportunities for competitors to capture market share while Bristol Laboratories addresses the recall.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor for updates on the recall resolution and any regulatory actions taken by health authorities.
Related companies & assets
Companies
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.